DR REDDYS (NYSE: RDY) CFO reports direct ownership of 61,245 shares

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD Chief Financial Officer Mannam Venkata Narasimham filed an initial ownership report showing his stake in the company. The Form 3 lists direct ownership of 61,245 Equity Shares, providing a baseline of his holdings as an executive but does not report any recent share purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MANNAM VENKATA NARASIMHAM

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Equity Shares	--	--	--

Holdings After Transaction: Equity Shares — 61,245 shares (Direct)

Footnotes (1)

Key Figures

CFO direct holdings: 61,245 Equity Shares Buy transactions: 0 shares Sell transactions: 0 shares

3 metrics

CFO direct holdings 61,245 Equity Shares Total shares directly owned following reported holdings

Buy transactions 0 shares No buy transactions reported in this Form 3

Sell transactions 0 shares No sell transactions reported in this Form 3

Key Terms

Form 3, Equity Shares, beneficial ownership

3 terms

Form 3 regulatory

"filed an initial ownership report showing his stake in the company"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Equity Shares financial

"The Form 3 lists direct ownership of 61,245 Equity Shares"

Equity shares are units of ownership in a company that give the holder a claim on a portion of its assets and profits, like owning a slice of a business. They matter to investors because their value can rise or fall with the company’s performance and market sentiment, may provide periodic income through dividends, and often carry voting rights that influence how the business is run.

beneficial ownership financial

"This figure reflects his reported beneficial ownership and helps investors"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MANNAM VENKATA NARASIMHAM

(Last) (First) (Middle)

VILLA NO-147, SURVEY NO-79,

VASANTHA CITY, BIKSHAPATHI NAGAR

(Street)

HYDERABAD TELANGANA 500049

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares	61,245	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ M V NARASIMHAM	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing by RDY CFO Mannam Venkata Narasimham show?

The Form 3 shows that RDY Chief Financial Officer Mannam Venkata Narasimham directly owns 61,245 Equity Shares. This is an initial ownership report, establishing his existing stake as an executive without indicating any new purchase or sale activity.

Is the RDY CFO buying or selling shares in this Form 3 filing?

The filing does not report any buying or selling activity. It is an initial ownership statement listing the CFO’s direct holding of 61,245 Equity Shares, serving as a disclosure baseline rather than a record of recent transactions.

How many DR REDDYS LABORATORIES LTD shares does the CFO hold according to this filing?

According to the Form 3, the Chief Financial Officer directly holds 61,245 Equity Shares of DR REDDYS LABORATORIES LTD. This figure reflects his reported beneficial ownership and helps investors understand insider equity alignment at the company.

Does the RDY Form 3 filing include any derivative securities for the CFO?

The Form 3 shows no derivative securities reported for the CFO. Only direct ownership of 61,245 Equity Shares is disclosed, so there are no listed options, warrants, or other derivative positions in this particular filing.

Why is the RDY CFO’s Form 3 important for investors?

The Form 3 is important because it discloses the CFO’s 61,245 Equity Shares holding, giving insight into his direct equity stake. Such insider ownership disclosures help investors gauge executive alignment with shareholder interests over time.